Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Peripheral Nervous System Diseases 3Lymphoma 3Lymphoma, Large B-Cell, Diffuse 2Breast Neoplasms 2Wilms Tumor 1Vaso-Occlusive Crises 1Sarcoma 1Prostatic Neoplasms 1Pain 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Lymphoma, Non-Hodgkin 1Lymphoma, Extranodal NK-T-Cell 1Leukemia 1Kidney Neoplasms 1Esophagitis 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Anemia, Sickle Cell 1

Interventions

Rituximab 155Cyclophosphamide 120fludarabine phosphate 71Whole-Body Irradiation 55Mycophenolic Acid 54Etoposide 53Peripheral Blood Stem Cell Transplantation 46fludarabine 45Melphalan 44Granulocyte Colony-Stimulating Factor 43Busulfan 43Tacrolimus 39Filgrastim 37Vincristine 33Cyclosporine 31Bendamustine Hydrochloride 31Prednisone 29Doxorubicin 29Antilymphocyte Serum 28Methotrexate 27Cytarabine 27Lenalidomide 23Carmustine 22Bortezomib 22plerixafor 20Dexamethasone 19Thiotepa 17Stem Cell Transplantation 17Radiotherapy 17tositumomab I-131 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, Non-Hodgkin × Glutamine × Clear all
NCT01983969 2020-01-27

Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma

M.D. Anderson Cancer Center

Phase 1/2 Completed
61 enrolled 10 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡